(R)-2-AMINO-3-CYCLOPROPYL-PROPIONIC ACID - Names and Identifiers
(R)-2-AMINO-3-CYCLOPROPYL-PROPIONIC ACID - Physico-chemical Properties
Molecular Formula | C6H11NO2
|
Molar Mass | 129.16 |
Density | 1.218±0.06 g/cm3(Predicted) |
Boling Point | 258.0±23.0 °C(Predicted) |
Flash Point | 101.6°C |
Vapor Presure | 0.00994mmHg at 25°C |
Appearance | White crystal |
pKa | 2.32±0.10(Predicted) |
Storage Condition | Keep in dark place,Inert atmosphere,Room temperature |
Refractive Index | 1.496 |
MDL | MFCD02259520 |
(R)-2-AMINO-3-CYCLOPROPYL-PROPIONIC ACID - Introduction
D-3-(cyclopropyl) alanine, also known as D-cyclohexylalanine, is a chiral compound containing a cyclopropyl substituted aspartic acid.
Regarding the properties of D-3-(cyclopropyl) alanine, it is a white crystalline solid with low solubility at room temperature. It is almost insoluble in water, but has high solubility in some organic solvents, such as ethanol and ester solvents.
The use of D-3-(cyclopropyl) alanine is mainly concentrated in the field of organic synthesis. As a chiral inducer, it can be used in the synthesis of chiral compounds, drugs and pesticides. D-3-(cyclopropyl) alanine can also be used in protein engineering and peptide drug research.
The method of preparing D-3-(cyclopropyl) alanine is usually through the synthesis and chiral separation of amino acids. A common synthesis method is the condensation reaction of a suitable cyclopropene substrate with chiral alanine and chiral separation under appropriate conditions.
Regarding safety information, D-3-(cyclopropyl) alanine is relatively safe under general conditions of use. However, it is still necessary to comply with laboratory safety regulations during operation, such as wearing personal protective equipment and taking care to avoid inhalation and contact. In addition, the compound should be stored properly and avoid mixing with other harmful chemicals to ensure safety. It is recommended that D-3-(cyclopropyl) alanine be used under the guidance of a professional if necessary.
Last Update:2024-04-09 21:54:55